InflaRx Reports Third Quarter 2021 Financial & Operating Results

NEXT STORY
Crinetics Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex, Inc. Reports First Quarter Ended March 31, 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Iterum Therapeutics Reports Second Quarter 2020 Financial Results

author_avatar
NASDAQ Market News

Research Provides New Insight on Functional Changes That Regular Coffee Drinking has on The Brain

author_avatar
NASDAQ Market News